Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation

scientific article published on 01 November 1998

Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0041-1345(98)01193-2
P698PubMed publication ID9838617

P2093author name stringT Kraus
E Klar
C Herfarth
M Angelescu
C Zapletal
M Bredt
P2860cites workExtended preservation of human liver grafts with UW solutionQ34197428
Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solutionQ34248787
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injuryQ42574211
First clinical realization of continuous monitoring of liver microcirculation after transplantation by thermodiffusionQ44814708
Effect of extended cold ischaemia with UW solution on graft function after liver transplantationQ61866794
Hepatic tissue oxygenation as a predictive indicator of ischemia-reperfusion liver injuryQ68070322
The impact of extended preservation on clinical liver transplantationQ68924057
Risk factors for primary dysfunction after liver transplantation--a multivariate analysisQ70665180
Early assessment of reperfusion injury by intraoperative quantification of hepatic microcirculation in patientsQ73278050
P433issue7
P304page(s)3683-3685
P577publication date1998-11-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleDefinition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation
P478volume30

Reverse relations

cites work (P2860)
Q74617118Histomorphological analysis of preservation injury as determinant of graft quality in clinical liver transplantation
Q45203390Influence of cold ischemia time on complement activation, neopterin, and cytokine release in liver transplantation
Q41182027Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution
Q34552111Polyethylene glycol rinse solution: an effective way to prevent ischemia-reperfusion injury
Q43553025Prediction of primary graft failure by intraoperative quantification of liver perfusion
Q39488133Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.
Q42849607Relevance of Epidermal Growth Factor to Improve Steatotic Liver Preservation in IGL-1 Solution
Q35977888The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models
Q43832259The economic impact of preservation time in cadaveric liver transplantation
Q40977230Trimetazidine: is it a promising drug for use in steatotic grafts?

Search more.